Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DIACYLETHYLENEDIAMINE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2010/122968
Kind Code:
A1
Abstract:
Disclosed is a compound useful as an anti-obesity agent. Studies have been made on compounds which have a DGAT1 inhibitory activity and are therefore promising active ingredients for pharmaceutical compositions for treating obesity, type-II diabetes, fatty liver and diseases associated with the aforementioned diseases, and it is confirmed that a specific diacylethylenediamine compound has an excellent DGAT1 inhibitory activity. The diacylethylenediamine compound has a DGAT1 inhibitory activity and can be used as a prophylactic and/or therapeutic agent for obesity, type-II diabetes, fatty liver and diseases associated with the aforementioned diseases.

Inventors:
KAWANO TOMOAKI (JP)
YONETOKU YASUHIRO (JP)
HANAZAWA TAKESHI (JP)
NIGAWARA TAKAHIRO (JP)
FUKUDOME HIROKI (JP)
MORITANI HIROSHI (JP)
Application Number:
PCT/JP2010/056901
Publication Date:
October 28, 2010
Filing Date:
April 19, 2010
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ASTELLAS PHARMA INC (JP)
KAWANO TOMOAKI (JP)
YONETOKU YASUHIRO (JP)
HANAZAWA TAKESHI (JP)
NIGAWARA TAKAHIRO (JP)
FUKUDOME HIROKI (JP)
MORITANI HIROSHI (JP)
International Classes:
C07C235/46; A61K31/343; A61K31/351; A61K31/357; A61K31/36; A61K31/381; A61K31/40; A61K31/402; A61K31/4035; A61K31/404; A61K31/41; A61K31/415; A61K31/421; A61K31/4245; A61K31/425; A61K31/427; A61K31/428; A61K31/4365; A61K31/439; A61K31/44; A61K31/445; A61K31/451; A61K31/4535; A61K31/4545; A61K31/455; A61K31/47; A61K31/495; A61K31/4985; A61K31/505; A61K31/5375; A61P1/16; A61P3/04; A61P3/10; A61P43/00; C07C235/84; C07C237/34; C07C255/46; C07C275/26; C07C275/28; C07C307/06; C07C311/51; C07C317/44; C07C323/62; C07D207/06; C07D209/08; C07D209/42; C07D209/44; C07D211/16; C07D211/34; C07D211/44; C07D211/60; C07D213/81; C07D213/82; C07D215/48; C07D217/26; C07D231/22; C07D239/42; C07D241/04; C07D257/04; C07D263/32; C07D263/34; C07D263/48; C07D271/06; C07D271/10; C07D275/02; C07D277/20; C07D277/56; C07D277/68; C07D295/14; C07D295/18; C07D295/20; C07D307/79; C07D309/06; C07D317/46; C07D319/18; C07D333/38; C07D333/54; C07D333/68; C07D333/70; C07D451/02; C07D495/04
Domestic Patent References:
WO2008011131A22008-01-24
WO2006082952A12006-08-10
WO2008011130A22008-01-24
WO2008011131A22008-01-24
WO2007141517A12007-12-13
WO2007138304A12007-12-06
WO2007138311A12007-12-06
WO2006064189A12006-06-22
WO2009076618A22009-06-18
WO2007115935A12007-10-18
Foreign References:
JPH0377881A1991-04-03
Other References:
See also references of EP 2423182A4
PROC. NAT. ACAD. SCI., vol. 95, 1998, pages 13018 - 13023
J. BIOL. CHEM., vol. 276, 2001, pages 38870 - 38876
NATURE GENETICS, vol. 25, 2000, pages 87 - 90
J. CLIN. INVEST., vol. 109, 2002, pages 1049 - 1055
ARTERIOSCLER. THROMB. VASE. BIOL., vol. 25, 2005, pages 482 - 486
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, vol. 25, no. 2, 2009, pages 178 - 182
PROG. MED., vol. 5, 1985, pages 2157 - 2161
"Drug Design", vol. 7, 1990, HIROKAWA PUBLISHING COMPANY, article "Pharmaceutical Research and Development", pages: 163 - 198
P. G. M. WUTS; T. W. GREENE: "Greene's Protective Groups in Organic Synthesis", 2006
"Greene's Protective Groups in Organic Synthesis", 2006
JOURNAL OF MEDICINAL CHEMISTRY, vol. 36, no. 24, 1993, pages 3968 - 3970
Attorney, Agent or Firm:
MORITA, Hiroshi et al. (JP)
Morita 拓 (JP)
Download PDF: